CompX International Inc. (NYSEAMERICAN: CIX) stock suffered a major decline of -19.3% on 5/8/24. The shares closed at $27.60. Moreover, unusually high trading volume at 157% of normal accompanied the decline. The stock has been […]
For its second fiscal quarter (ending March 31), Blue Bird Corp (NASDAQ: BLBD) has reported a 268% increase in E.P.S. from $0.22 a year ago to $0.81 in the current quarter. This performance was $0.25 […]
Alpha and Omega Semiconductor Li (NASDAQ: AOSL) stock enjoyed a major increase of 20.9% on 5/8/24. The shares closed at $26.93. Moreover, this advance was accompanied by exceptionally high trading volume at 487% of normal. […]
Over the next 6 years, Canopy Growth shares will need to reach $17 to achieve average annual stock market performance of 9.0%. Canopy Growth’s stock price will need to reach $20 by 2029 to achieve […]
iRobot Corp (NASDAQ: IRBT) stock enjoyed a major increase of 21.1% on 5/8/24. The shares closed at $10.92. Moreover, exceptionally high trading volume at 286% of normal accompanied the advance. The stock has been extremely […]
For its first fiscal quarter (ending March 31), Watts Water Technologies Inc (NYSE: WTS) has reported a 12% increase in E.P.S. from $1.94 a year ago to $2.17 in the current quarter. However, this performance […]
Vericel Corp (NASDAQ: VCEL) has reported E.P.S. of $-0.08 for its first fiscal quarter (ending March 31) versus $-0.16 for the same period a year ago. Relative to the consensus estimate of $-0.04, this was […]
For its third fiscal quarter (ending March 31), The Hain Celestial Group Inc (NASDAQ: HAIN) has reported E.P.S. of $-0.54 compared to $-1.29 a year ago. This result fell short of the consensus estimate of […]
On 5/8/24, Teva Pharmaceutical Industries L (NYSE: TEVA) stock enjoyed a major increase of 12.8%, closing at $15.74. Moreover, exceptionally high trading volume at 406% of normal accompanied the advance. Relative to the market the […]
For its first fiscal quarter (ending March 31), Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has reported a -100% decline in E.P.S. from $0.31 a year ago to $0.00 in the current quarter. This performance was $-0.49 […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research